- Report
- February 2024
- 185 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- February 2024
- 304 Pages
Global
From €3480EUR$3,600USD£2,991GBP
- Report
- January 2023
- 117 Pages
Europe
From €2030EUR$2,100USD£1,745GBP
€2900EUR$3,000USD£2,493GBP
- Report
- January 2022
- 120 Pages
United States
From €4592EUR$4,750USD£3,947GBP
- Report
- March 2023
- 94 Pages
Global
From €4829EUR$4,995USD£4,150GBP
- Webinar
- 90 Minutes
Global
From €184EUR$190USD£158GBP
The New Drug Application (NDA) market is a segment of the pharmaceutical manufacturing industry that focuses on the development and approval of new drugs. It involves the submission of a detailed application to the relevant regulatory body, such as the US Food and Drug Administration (FDA), for the approval of a new drug. The application must include information on the safety and efficacy of the drug, as well as its manufacturing process. The NDA market is highly competitive, with companies vying to develop and bring to market the most effective and safe drugs. Companies must also ensure that their drugs meet the stringent regulatory requirements of the relevant authorities.
Some of the major players in the NDA market include Pfizer, Merck, GlaxoSmithKline, Novartis, Sanofi, AstraZeneca, and Johnson & Johnson. Show Less Read more